Physician profile
Quoc Le
NPI 1396787396
$17,424.32
in general payments reported to CMS, 2019-2025
62 companies · $2,218 in 2025
The $2,218 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,954 · 2020: $2,108 · 2021: $2,790 · 2022: $2,431 · 2023: $2,474 · 2024: $2,450 · 2025: $2,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,140.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,625.77 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,478.36 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $1,297.57 | 2019-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $868.39 | 2019-2025 | |
| Lilly USA, LLC | $856.08 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $705.66 | 2019-2025 | Xifaxan |
| Abbvie INC. | $668.83 | 2019-2025 | |
| Glaxosmithkline, LLC. | $662.43 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amarin Pharma, INC. | $614.77 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $581.48 | 2021-2025 | |
| Astellas Pharma US INC | $564.31 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $531.02 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $441.84 | 2019-2025 | |
| Optinose US, INC. | $430.05 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $330.16 | 2019-2025 | Verquvo, Belsomra, Lagevrio |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $228.80 | 2020-2023 | Xarelto |
| Paratek Pharmaceuticals, INC. | $220.42 | 2024-2025 | Nuzyra, Xhance |
| Abbott Laboratories | $216.38 | 2022-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Exact Sciences Corporation | $207.88 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $206.40 | 2020-2025 | Nexletol |
| Shield Therapeutics INC | $201.72 | 2023-2024 | Accrufer |
| Sanofi Pasteur INC. | $188.02 | 2019-2022 | |
| Dexcom, INC. | $187.21 | 2021-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $175.71 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $153.23 | 2019-2020 | |
| Stryker Corporation | $139.23 | 2019 | |
| Hologic Sales and Service, LLC | $137.51 | 2020-2025 | Thinprep 2000 Processor |
| Aimmune Therapeutics, INC. | $132.41 | 2024-2025 | Zenpep |
| Novartis Pharmaceuticals Corporation | $110.83 | 2019-2022 | |
| Intuitive Surgical, INC. | $92.21 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $91.62 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $86.64 | 2021-2022 | |
| Inspire Medical Systems, INC. | $68.01 | 2023-2025 | Inspire |
| Avanir Pharmaceuticals, INC. | $59.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $58.37 | 2019-2022 | |
| Kaleo, INC. | $55.09 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $51.30 | 2023-2024 | Horizant, Edarbi, Horizant |
| Alk-Abello, INC | $45.38 | 2021-2022 | |
| Scynexis, INC. | $44.86 | 2022 | |
| Currax Pharmaceuticals LLC | $44.70 | 2020-2025 | Contrave |
| Gilead Sciences, INC. | $43.78 | 2021-2024 | |
| Phadia US INC. | $42.09 | 2020-2024 | Immunocap |
| Edwards Lifesciences Corporation | $36.11 | 2025 | Sapien 3 Ultra Resilia |
| Eisai INC. | $35.60 | 2020-2021 | |
| Dynavax Technologies Corporation | $33.21 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $32.44 | 2021 | |
| Radius Health, INC. | $31.72 | 2019 | |
| Xeris Pharmaceuticals, INC. | $30.13 | 2022-2025 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $28.27 | 2024 | Quviviq |
| Althera Pharmaceuticals LLC | $24.74 | 2022 | |
| Medtronic, INC. | $23.43 | 2024 | Intellis Adaptivestim |
| Shire North American Group INC | $22.80 | 2019 | |
| Verona Pharma, INC. | $21.75 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $21.18 | 2019 | |
| Axsome Therapeutics, INC. | $18.98 | 2025 | Symbravo |
| Hikma Pharmaceuticals USA | $18.72 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.71 | 2023 | Dupixent |
| Seqirus USA INC | $18.25 | 2025 | Fluad, Flucelvax |
| Medtronic Vascular, INC. | $17.08 | 2019 | |
| Cleerly, INC. | $15.54 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Inari Medical, INC. | $15.11 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sumitomo Pharma America, INC. | $14.26 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quoc Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.